Xerthra PRP Pure kit

PLATELET-RICH PLASMA WITHOUT LEUKOCYTES LP-PRP (leukocyte-poor PRP)

Indications:

initial stage of OA without increased level of inflammation.

Effectiveness of platelet rich plasma therapy depends on platelets amount contained in autologous plasma, because it has a direct impact on the growth factors amount in the product. Only concentration of platelet >1 million PLT/μl ensures the effectiveness of the therapy.
The highest concentration of platelets can only be obtained with specially dedicated devices. XerthraTM separation device allows on average 1.5 million PLT/μl to be obtained, what gives 8 times higher concentration than in the peripheral blood.